BrainChip (BRN) Q3 2025 earnings summary

Executive summary

• Ended the quarter with a cash balance of $13.9M, up from $13.5M in the prior quarter.

• Advanced AKD1500 neuromorphic processor from reference design to volume production, driven by strong customer engagement in defense, aerospace, medical, and consumer wearables.

• Expanded global IP portfolio to 57 issued and pending patents, reinforcing competitive positioning in edge AI.

• Entered strategic supply agreement with Parsons Corporation for AKD1500 integration into defense platforms.

• Broadened distribution through DigiKey, making Akida-based development boards globally accessible.

Financial highlights

• Net operating cash outflows of $4.9M, higher than $2.8M in the prior quarter.

• Customer cash inflows of $0.3M, down from $1.4M in the previous quarter due to lower engineering revenues.

• Payments to suppliers and employees totaled $5.2M, up from $4.4M, reflecting merit increases, higher contractor fees, and corporate costs.

• Cash inflows from financing activities of $5.4M from a capital call, with an average subscription price of A$0.2059 per share.

• Estimated 2.96 quarters of funding available based on current cash burn and available facilities.

Outlook and guidance

• Volume production of AKD1500 expected to drive scalable revenue growth, supported by strategic agreements and expanded distribution.

• Enhanced full-stack AI capabilities position the company as a comprehensive AI solutions provider.